Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Cervical Cancer » Stats
 

Statistics about Cervical Cancer

Prevalence and incidence statistics for Cervical Cancer:

See also prevalence and incidence page for Cervical Cancer

Incidence (annual) of Cervical Cancer: 13,000 annual cases in USA (SEER 2002 estimate)

Incidence Rate: approx 1 in 20,923 or 0.00% or 13,000 people in USA [about data]

Incidence extrapolations for USA for Cervical Cancer: 13,000 per year, 1,083 per month, 250 per week, 35 per day, 1 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the incidence statistic: 13,000 annual cases in USA (SEER 2002 estimate)

Lifetime risk for Cervical Cancer: 1 in 117 lifetime risk for women in the US (Cancer Facts and Figures, American Cancer Society, 2004)

Prevalance of Cervical Cancer: The American Cancer Society estimated that about 12,800 women in the United States were diagnosed with invasive cervical cancer in 2000. (Source: excerpt from HPV: DSTD)

Incidence of Cervical Cancer: An estimated 13,700 cases of invasive cervical cancer will be diagnosed in the United States in 1998. (Source: excerpt from Sexually Transmitted Diseases Statistics, NIAID Fact Sheet: NIAID)

Cervical Cancer: Rare Disease Status

Cervical Cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD)...more »

Incidence statistics about Cervical Cancer:

The following statistics relate to the incidence of Cervical Cancer:

  • 10,520 new cases for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 10,520 new female cases for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Estimated 13,000 new cases in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Cervix cancer incidence statistics by racial groups in the USA:
    • 9.2 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 12.4 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 10.2 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 6.9 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 16.8 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Cervical cancer incidence rates in various countries:
    • 29.8 women per 100,000 population with cervical cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 17.1 women per 100,000 population with cervical cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 16.1 women per 100,000 population with cervical cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 14.4 women per 100,000 population with cervical cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 13.9 women per 100,000 population with cervical cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 12.7 women per 100,000 population with cervical cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 12.3 women per 100,000 population with cervical cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 8.2 women per 100,000 population with cervical cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 7.7 women per 100,000 population with cervical cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 7.4 women per 100,000 population with cervical cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 7.3 women per 100,000 population with cervical cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 7.1 women per 100,000 population with cervical cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 1,350 new cases of cervical cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 8 per 100,000 new cases of cervical cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Cervical cancer incidence rates in various countries:
    • 14.2 new cases per 100,000 population for cervical cancer in Argentina 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 22.1 new cases per 100,000 population for cervical cancer in Bahamas 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 30.4 new cases per 100,000 population for cervical cancer in Barbados 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 39.6 new cases per 100,000 population for cervical cancer in Belize 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 58.1 new cases per 100,000 population for cervical cancer in Bolivia 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 31.3 new cases per 100,000 population for cervical cancer in Brazil 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 8.2 new cases per 100,000 population for cervical cancer in Canada 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 29.2 new cases per 100,000 population for cervical cancer in Chile 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 32.9 new cases per 100,000 population for cervical cancer in Colombia 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 25 new cases per 100,000 population for cervical cancer in Costa Rica 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 23.8 new cases per 100,000 population for cervical cancer in Cuba 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 38.4 new cases per 100,000 population for cervical cancer in Dominican Republic 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 44.2 new cases per 100,000 population for cervical cancer in Ecuador 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 40.6 new cases per 100,000 population for cervical cancer in El Salvador 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 39.6 new cases per 100,000 population for cervical cancer in Guatemala 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 51.1 new cases per 100,000 population for cervical cancer in Guyana 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 93.9 new cases per 100,000 population for cervical cancer in Haiti 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 39.6 new cases per 100,000 population for cervical cancer in Honduras 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 43.4 new cases per 100,000 population for cervical cancer in Jamaica 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 40.5 new cases per 100,000 population for cervical cancer in Mexico 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 61.1 new cases per 100,000 population for cervical cancer in Nicaragua 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 31.2 new cases per 100,000 population for cervical cancer in Panama 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 41.1 new cases per 100,000 population for cervical cancer in Paraguay 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 39.9 new cases per 100,000 population for cervical cancer in Peru 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 10.3 new cases per 100,000 population for cervical cancer in Puerto Rico 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 43.8 new cases per 100,000 population for cervical cancer in Suriname 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 33.3 new cases per 100,000 population for cervical cancer in Trinidad and Tobago 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 7.8 new cases per 100,000 population for cervical cancer in the US 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 13.8 new cases per 100,000 population for cervical cancer in Uruguay 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
    • 38.3 new cases per 100,000 population for cervical cancer in Venezuela 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 10 new female cases of cervical cancer per 100,000 population aged 20-74 in Australia 2000 (Australia’s Health 2004, AIHW)
  • Incidence statistics by state in Australia:
    • 9.1 new female cases of cervical cancer occurred per 100,000 population in New South Wales 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 7.9 new female cases of cervical cancer occurred per 100,000 population in Victoria 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 10 new female cases of cervical cancer occurred per 100,000 population in Queensland 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 8.5 new female cases of cervical cancer occurred per 100,000 population in Western Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 6.8 new female cases of cervical cancer occurred per 100,000 population in South Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 9.5 new female cases of cervical cancer occurred per 100,000 population in Tasmania 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 7.3 new female cases of cervical cancer occurred per 100,000 population in Australian Capital Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 15.9 new female cases of cervical cancer occurred per 100,000 population in Northern Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • more about incidence...»

Death and mortality statistics for Cervical Cancer:

Deaths from Cervical Cancer: approximately 4,600 women will die in 2001 (DSTD)

Death rate extrapolations for USA for Cervical Cancer: 4,599 per year, 383 per month, 88 per week, 12 per day, 0 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the deaths statistic: approximately 4,600 women will die in 2001 (DSTD)

Death statistics for Cervical Cancer:

The following are statistics from various sources about deaths and Cervical Cancer:

  • 4,205 deaths reported in USA 1999 (NVSR Sep 2001)
  • 3,900 estimated deaths for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 3,900 estimated female deaths for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 2 per 100,000 deaths in women from cervical cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 410 deaths in women from cervical cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Mortality rates for cervical cancer deaths by racial groups in the USA:
    • 2.7 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 5.9 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 2.9 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 2. American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 3.7 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Mortality rates for cervical cancer in various countries:
    • 3.3 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.4 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.9 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.4 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.8 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.6 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.1 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.7 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.7 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.6 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.2 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.7 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.3 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.5 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.2 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.7 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.1 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.0 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.1 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.3 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.6 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.8 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.3 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.6 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.1 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.3 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.8 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.8 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.0 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.9 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.2 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.4 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.6 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.7 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.9 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.0 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.3 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.2 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • 2 women aged 20-74 per 100,000 population die of cervical cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • more about deaths...»

Deaths from Cervical Cancer

In 2001, approximately 4,600 women will die from cervical cancer. (Source: excerpt from HPV: DSTD) ... In 1998, an estimated 4,800 American women will die of cervical cancer. (Source: excerpt from Sexually Transmitted Diseases Statistics, NIAID Fact Sheet: NIAID)

Survival Rate & Life Expectancy for Cervical Cancer

Survival rate for Cervical Cancer: 47% survival rate for cervical cancer in the UK 2001 (National Statistics – UK Government Census, 2001)

Survival rate statistics for Cervical Cancer:

The following are statistics from various sources about the survival rate for Cervical Cancer:

  • 67.4% of people with cervical cancer survive after 5 years in the US 1983-90 (SEER)
  • 73% of white people survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 61% of African American people survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 71% survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 58% of women aged 20-74 survive five years after cervical cancer diagnosis in Australia 1992-97 (Cancer Survival in Australia, 1992-97, Australia’s Health 2004, AIHW)
  • 5-year survival rate for black women with cervix uteri cancer is 56.4% in the US 1983-90 (SEER)
  • 5-year survival rate for white women with cervix uteri cancer is 69.9% in the US 1983-90 (SEER)
  • 5-year survival rate for women with cervix uteri cancer is 67.4% in the US 1983-90 (SEER)
  • 1-year survival rate for women aged 15-99 with cervical cancer is 82.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with cervical cancer is 62.2% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with cervical cancer is 94% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with cervical cancer is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with cervical cancer is 90% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with cervical cancer is 73% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with cervical cancer is 84% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with cervical cancer is 62% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with cervical cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with cervical cancer is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with cervical cancer is 65% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with cervical cancer is 37% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with cervical cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with cervical cancer is 25% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • more about deaths...»

Life Expectancy & Years of Life Lost for Cervical Cancer

Average life years lost for Cervical Cancer: 25.3 years (SEER)1

Society statistics for Cervical Cancer

  Costs for Cervical Cancer: approximately $737 million

  Costs for Cervical Cancer: Total costs associated with HPV-related cervical cancer totalled approximately $737 million in the United States in 1994. (Source: excerpt from Sexually Transmitted Diseases Statistics, NIAID Fact Sheet: NIAID)

Cost statistics for Cervical Cancer:

The following are statistics from various sources about costs and Cervical Cancer:

  • $88.2 million spent on cervical screening in Australia 2000-01(Australia’s Health 2004, AIHW)

Hospitalization statistics for Cervical Cancer:

The following are statistics from various sources about hospitalizations and Cervical Cancer:

  • 0.064% (8,213) of hospital consultant episodes were for malignant neoplasm of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 96% of hospital consultant episodes for malignant neoplasm of cervix uteri required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 100% of hospital consultant episodes for malignant neoplasm of cervix uteri were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 14% of hospital consultant episodes for malignant neoplasm of cervix uteri required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 6 days was the mean length of stay in hospitals for malignant neoplasm of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2 days was the median length of stay in hospitals for malignant neoplasm of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 52 was the mean age of patients hospitalised for malignant neoplasm of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 67% of hospital consultant episodes for malignant neoplasm of cervix uteri occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12% of hospital consultant episodes for malignant neoplasm of cervix uteri occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 27% of hospital consultant episodes for malignant neoplasm of cervix uteri were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • % (32,876) of hospital bed days were for malignant neoplasm of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.07% (8,863) of hospital consultant episodes were for carcinoma in situ of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 100% of hospital consultant episodes for carcinoma in situ of cervix uteri required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 100% of hospital consultant episodes for carcinoma in situ of cervix uteri were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 1 of hospital consultant episodes for carcinoma in situ of cervix uteri required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2.9 days was the mean length of stay in hospitals for carcinoma in situ of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 1 days was the median length of stay in hospitals for carcinoma in situ of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 34 was the mean age of patients hospitalised for carcinoma in situ of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 96% of hospital consultant episodes for carcinoma in situ of cervix uteri occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0% of hospital consultant episodes for carcinoma in situ of cervix uteri occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 80% of hospital consultant episodes for carcinoma in situ of cervix uteri were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.008% (4,349) of hospital bed days were for carcinoma in situ of cervix uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Cervical Cancer. The term 'prevalence' of Cervical Cancer usually refers to the estimated population of people who are managing Cervical Cancer at any given time. The term 'incidence' of Cervical Cancer refers to the annual diagnosis rate, or the number of new cases of Cervical Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes: 1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise